The influence of selenium and selenoprotein gene variants on colorectal cancer risk

Mutagenesis

Volumn 27, Issue 2, 2012, Pages 177-186

  Méplan, Catherine ^a   Hesketh, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE TYPE I; DEIODINASE TYPE II; DEIODINASE TYPE III; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE PEROXIDASE 6; IODIDE PEROXIDASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPHOSPHATE SYNTHETASE 2; SELENOPROTEIN; SELENOPROTEIN 15; SELENOPROTEIN H; SELENOPROTEIN I; SELENOPROTEIN K; SELENOPROTEIN M; SELENOPROTEIN N; SELENOPROTEIN O; SELENOPROTEIN P; SELENOPROTEIN S; SELENOPROTEIN T; SELENOPROTEIN V; SELENOPROTEIN W; SYNTHETASE; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; THIOREDOXIN REDUCTASE 3; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER RISK; CELLULAR STRESS RESPONSE; CLINICAL TRIAL (TOPIC); COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; DIETARY FIBER; DIETARY INTAKE; ENDOPLASMIC RETICULUM STRESS; EPIDEMIOLOGICAL DATA; EPITHELIUM CELL; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INTRON; NONHUMAN; OXIDATIVE STRESS; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SELENIUM; SELENOPROTEINS;

EID: 84856862119     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger058     Document Type: Article

References (86)

1. Rayman, M. P. (2009) Selenoproteins and human health: insights from epidemiological data. Biochim. Biophys. Acta, 1790, 1533-1540.
2. Whanger, P. D. (2004) Selenium and its relationship to cancer: an update dagger. Br. J. Nutr., 91, 11-28. (Pubitemid 38100556)
3. Rayman, M. P. (2000) The importance of selenium to human health. Lancet, 356, 233-241. (Pubitemid 30446984)
4. Rayman, M. P. (2002) The argument for increasing selenium intake. Proc. Nutr. Soc., 61, 203-215. (Pubitemid 34665794)
5. Johnson, C. C., Fordyce, F. M. and Rayman, M. P. (2010) Symposium on 'Geographical and geological influences on nutrition': factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc. Nutr. Soc., 69, 119-132.
6. Bellinger, F. P., Raman, A. V., Reeves, M. A. and Berry, M. J. (2009) Regulation and function of selenoproteins in human disease. Biochem. J., 422, 11-22.
7. Esworthy, R. S., Aranda, R., Martin, M. G., Doroshow, J. H., Binder, S. W. and Chu, F. F. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G848-G855.
8. Brigelius-Flohe, R. (1999) Tissue-specific functions of individual glutathi-one peroxidases. Free Radic. Biol. Med., 27, 951-965. (Pubitemid 29507469)
9. Kohrle, J. (2005) Selenium and the control of thyroid hormone metabolism. Thyroid, 15, 841-853. (Pubitemid 41339263)
10. Burk, R. F. and Hill, K. E. (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochim. Biophys. Acta, 1790, 1441-1447.
11. Méplan, C., Nicol, F., Burtle, B. T., Crosley, L. K., Arthur, J. R., Mathers, J. C. and Hesketh, J. E. (2009) Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid. Redox Signal., 11, 2631-2640.
12. Hill, K. E., Zhou, J., Mc Mahan, W. J., Motley, A. K., Atkins, J. F., Gesteland, R. F. and Burk. (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem., 278, 13640-13646. (Pubitemid 36799899)
13. Schomburg, L., Schweizer, U., Holtmann, B., Flohe, L., Sendtner, M. and Kohrle, J. (2003) Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J., 370, 397-402. (Pubitemid 36315127)
14. Al-Taie, O. H., Uceyler, N., Eubner, U. et al. (2004) Expression profiling and genetic alterations of the selenoproteins GI-GPx and Se PP in colorectal carcinogenesis. Nutr. Cancer, 48, 6-14. (Pubitemid 38823541)
15. Kelly, E., Greene, C. M., Carroll, T. P., Mc Elvaney, N. G. and O'Neill, S. J. (2009) Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant alpha1-antitrypsin deficiency. J. Biol. Chem., 284, 16891-16897.
16. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L. and Gladyshev, V. N. (2001) Association between the 15-k Da selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem., 276, 15330-15336.
17. Petit, N., Lescure, A., Rederstorff, M., Krol, A., Moghadaszadeh, B., Wewer, U. M. and Guicheney, P. (2003) Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum. Mol. Genet., 12, 1045-1053. (Pubitemid 36553524)
18. Reeves, M. A., Bellinger, F. P. and Berry, M. J. (2010) The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid. Redox Signal., 12, 809-818.
19. Bermano, G., Nicol, F., Dyer, J. A., Sunde, R. A., Beckett, G. J., Arthur, J. R. and Hesketh, J. E. (1995) Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J., 311, 425-430.
20. Hoffmann, P. R., Hoge, S. C., Li, P. A., Hoffmann, F. W., Hashimoto, A. C. and Berry, M. J. (2007) The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res., 35, 3963-3973. (Pubitemid 47244618)
21. Sunde, R. A., Raines, A. M., Barnes, K. M. and Evenson, J. K. (2009) Selenium status highly regulates selenoprotein m RNA levels for only a subset of the selenoproteins in the selenoproteome. Biosci. Rep., 29, 329-338.
22. Pagmantidis, V., Bermano, G., Villette, S., Broom, I., Arthur, J. and Hesketh, J. (2005) Effects of Se-depletion on glutathione peroxidase and selenoprotein W gene expression in the colon. FEBS Lett., 579, 792-796.
23. Kipp, A., Banning, A., van Schothorst, E. M. et al. (2009) Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol. Nutr. Food Res., 53, 1561-1572.
24. Hesketh, J. and Meplan, C. (2011) Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. Proc. Nutr. Soc., May 3 [Epub ahead of print] PMID: 21557886.
25. Shamberger, R. J. and Frost, D. V. (1969) Possible protective effect of selenium against human cancer. Can. Med. Assoc. J., 100, 682.
26. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W. et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-1963. (Pubitemid 26427723)
27. Duffield-Lillico, A. J., Reid, M. E., Turnbull, B. W., Combs, G. F., Jr., Slate, E. H., Fischbach, L. A., Marshall, J. R. and Clark, L. C. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev., 11, 630-639. (Pubitemid 34760821)
28. Duffield, A. J., Thomson, C. D., Hill, K. E. and Williams, S. (1999) An estimation of selenium requirements for New Zealanders. Am. J. Clin. Nutr., 70, 896-903. (Pubitemid 29512917)
29. Garland, M., Morris, J. S., Stampfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K. et al. (1995) Prospective study oftoenail selenium levels and cancer among women. J. Natl Cancer Inst., 87, 497-505.
30. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M. et al. (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl Cancer Inst., 82, 864-868. (Pubitemid 20149447)
31. Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D. and Lacroix, A. (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect. Prev., 24, 305-313.
32. van den Brandt, P. A., Goldbohm, R. A., van 't Veer, P., Bode, P., Dorant, E., Hermus, R. J. et al. (1993) A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J. Natl Cancer Inst., 85, 224-229. (Pubitemid 23046898)
33. Nomura, A., Heilbrun, L. K., Morris, J. S. and Stemmermann, G. N. (1987) Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J. Natl Cancer Inst., 79, 103-108. (Pubitemid 17102555)
34. Nelson, R. L., Davis, F. G., Sutter, E., Kikendall, J. W., Sobin, L. H., Milner, J. A. and Bowen, P. E. (1995) Serum selenium and colonic neoplastic risk. Dis. Colon Rectum, 38, 1306-1310.
35. Clark, L. C., Hixson, L. J., Combs, G. F., Jr., Reid, M. E., Turnbull, B. W. and Sampliner, R. E. (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol. Bio-markers Prev., 2, 41-46.
36. Russo, M. W., Murray, S. C., Wurzelmann, J. I., Woosley, J. T. and Sandler, R. S. (1997) Plasma selenium levels and the risk of colorectal adenomas. Nutr. Cancer, 28, 125-129. (Pubitemid 27396198)
37. Peters, U., Chatterjee, N., Church, T. R., Mayo, C., Sturup, S., Foster, C. B., Schatzkin, A. and Hayes, R. B. (2006) High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol. Biomarkers Prev., 15, 315-320. (Pubitemid 43342181)
38. Wallace, K., Byers, T., Morris, J. S., Cole, B. F., Greenberg, E. R., Baron, J. A., Gudino, A., Spate, V. and Karagas, M. R. (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol. Biomarkers Prev., 12, 464-467. (Pubitemid 36578487)
39. Jacobs, E. T., Jiang, R., Alberts, D. S. etal. (2004) Selenium and colorectal adenoma: results of a pooled analysis. J. Natl Cancer Inst., 96, 1669-1675. (Pubitemid 39591588)
40. Peters, U. and Takata, Y. (2008) Selenium and the prevention of prostate and colorectal cancer. Mol. Nutr. Food Res., 52, 1261-1272.
41. Bleys, J., Navas-Acien, A. and Guallar, E. (2008) Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch. Intern. Med., 168, 404-410. (Pubitemid 351347132)
42. Bostick, R. M., Potter, J. D., Mc Kenzie, D. R., Sellers, T. A., Kushi, L. H., Steinmetz, K. A. and Folsom, A. R. (1993) Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res., 53, 4230-4237 (Pubitemid 24146771)
43. WCRF/AICR ed. (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC
44. Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D. and Tappenden, P. (2010) Chemo-prevention of colorectal cancer: systematic review and economic evaluation. Health Technol. Assess., 14, 1-206.
45. Fernández-Bañares, F., Cabré, E., Esteve, M., Mingorance, M. D., Abad-Lacruz, A., Lachica, M., Gil, A. and Gassull, M. A. (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am. J. Gastroenterol., 97, 2103-2108.
46. Hesketh, J. (2008) Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu. Rev. Nutr., 28, 157-177.
47. Forsberg, L., de Faire, U., Marklund, S. L., Andersson, P. M., Stegmayr, B. and Morgenstern, R. (2000) Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1. Blood Cells Mol. Dis., 26, 423-426. (Pubitemid 32037410)
48. Jablonska, E., Gromadzinska, J., Reszka, E., Wasowicz, W., Sobala, W., Szeszenia-Dabrowska, N. and Boffetta, P. (2009) Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur. J. Nutr., 48, 383-386.
49. Voetsch, B., Jin, R. C., Bierl, C. et al. (2007) Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke, 38, 41-49. (Pubitemid 46035604)
50. Villette, S., Kyle, J. A., Brown, K. M., Pickard, K., Milne, J. S., Nicol, F., Arthur, J. R. and Hesketh, J. E. (2002) A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis., 29, 174-178. (Pubitemid 35216411)
51. Méplan, C., Hughes, D. J., Pardini, B. et al. (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis, 31, 1074-1079.
52. Sutherland, A., Kim, D. H., Relton, C., Ahn, Y. O. and Hesketh, J. (2010) Polymorphisms in the selenoprotein S and 15-k Da selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr., 5, 215-223.
53. Méplan, C., Crosley, L. K., Nicol, F., Horgan, G. W., Mathers, J. C., Arthur, J. R. and Hesketh, J. E. (2008) Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxi-dase 4 gene: interaction with sex. Am. J. Clin. Nutr., 87, 1019-1027. (Pubitemid 351549249)
54. Bermano, G., Pagmantidis, V., Holloway, N. et al. (2007) Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutr., 2, 225-232.
55. Gautrey, H., Nicol, F., Sneddon, A. A., Hall, J. and Hesketh, J. (2011) A T/ C polymorphism in the GPX4 3'UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells. Biochim. Biophys. Acta, 1810, 284-291.
56. Méplan, C., Crosley, L. K., Nicol, F. et al. (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J., 21, 3063-3074. (Pubitemid 47565527)
57. Hu, Y. J., Korotkov, K. V., Mehta, R. et al. (2001) Distribution and functional consequences of nucleotide polymorphisms in the 3'-untrans-lated region of the human Sep15 gene. Cancer Res., 61, 2307-2310. (Pubitemid 32692064)
58. Curran, J. E., Jowett, J. B., Elliott, K. S. et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet., 37, 1234-1241. (Pubitemid 41568706)
59. Peters, U., Chatterjee, N., Hayes, R. B., Schoen, R. E., Wang, Y., Chanock, S. J. and Foster, C. B. (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., 17, 1144-1154.
60. Wang, J. Y., Yang, I. P., Wu, D. C., Huang, S. W., Wu, J. Y. and Juo, S. H. (2010) Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer. Clin. Chim. Acta, 411, 1432-1436.
61. Shibata, T., Arisawa, T., Tahara, T. et al. (2009) Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol., 9, 2.
62. Hu, Y., Mc Intosh, G. H., Le Leu, R. K. and Young, G. P. (2010) Selenium-enriched milk proteins and selenium yeast affect selenoprotein activity and expression differently in mouse colon. Br. J. Nutr., 104, 17-23.
63. Hu, Y., Mc Intosh, G. H., Le Leu, R. K., Upton, J. M., Woodman, R. J. and Young, G. P. (2011) The influence of selenium-enriched milk proteins and selenium yeast on plasma selenium levels and rectal selenoprotein gene expression in human subjects. Br. J. Nutr., 1-11.
64. Hu, Y., Mc Intosh, G. H., Le Leu, R. K., Woodman, R. and Young, G. P. (2008) Suppression of colorectal oncogenesis by selenium-enriched milk proteins: apoptosis and K-ras mutations. Cancer Res., 68, 4936-4944.
65. Irons, R., Carlson, B. A., Hatfield, D. L. and Davis, C. D. (2006) Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J. Nutr., 136, 1311-1317.
66. Yang, Y., Huang, F., Ren, Y., Xing, L., Wu, Y., Li, Z., Pan, H. and Xu, C. (2009) The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol. Res., 18, 1-8.
67. Klampfer, L. (2011) Cytokines, inflammation and colon cancer. Curr. Cancer Drug Targets, 11, 451-464.
68. Seiler, A., Schneider, M., Förster, H. et al. (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab., 8, 237-248.
69. Chu, F. F., Esworthy, R. S., Chu, P. G., Longmate, J. A., Huycke, M. M., Wilczynski, S. and Doroshow, J. H. (2004) Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res., 64, 962-968. (Pubitemid 38176898)
70. Arner, E. S. and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 267, 6102-6109.
71. Dreher, I., Jakobs, T. C. and Kohrle, J. (1997) Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. J. Biol. Chem., 272, 29364-29371. (Pubitemid 27498231)
72. Speckmann, B., Pinto, A., Winter, M., Forster, I., Sies, H. and Steinbrenner, H. (2010) Proinflammatory cytokines down-regulate in-testinal selenoprotein P biosynthesis via NOS2 induction. Free Radic. Biol. Med., 49, 777-785.
73. Müller, M., Banning, A., Brigelius-Flohé, R. and Kipp, A. (2010) Nrf2 target genes are induced under marginal selenium-deficiency. Genes Nutr., 5, 297-307.
74. Rajasekhar, V. K. and Holland, E. C. (2004) Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene, 23,3248-3264. (Pubitemid 38638836)
75. Rosenwald, I. B. (2004) The role of translation in neoplastic transformation from a pathologist's point ofview. Oncogene, 23, 3230-3247. (Pubitemid 38638835)
76. Proud, C. G. (2004) Role of m TOR signalling in the control of translation initiation and elongation by nutrients. Curr. Top. Microbiol. Immunol., 279, 215-244. (Pubitemid 37047265)
77. Schmidt, E. V., Ravitz, M. J., Chen, L. and Lynch, M. (2009) Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-m TOR pathway. Cell Cycle, 8, 1344-1351.
78. Banning, A., Deubel, S., Kluth, D., Zhou, Z. and Brigelius-Flohe, R. (2005) The GI-GPx gene is a target for Nrf2. Mol. Cell. Biol., 25, 4914-4923. (Pubitemid 40781093)
79. Hoffmann, P. R. and Berry, M. J. (2008) The influence of selenium on immune responses. Mol. Nutr. Food Res., 52, 1273-1280.
80. Nair, S., Doh, S. T., Chan, J. Y., Kong, A. N. and Cai, L. (2008) Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis. Br. J. Cancer, 99, 2070-2082.
81. Bellezza, I., Mierla, A. L. and Minelli, A. (2010) Nrf2 and NF-?B and their concerted modulation in cancer pathogenesis and progression. Cancers, 2, 483-497.
82. Li, X., Zhang, K. and Li, Z. (2011) Unfolded protein response in cancer: the physician's perspective. J. Hematol. Oncol., 4, 8.
83. Verfaillie, T., Salazar, M., Velasco, G. and Agostinis, P. (2010) Linking ER stress to autophagy: potential implications for cancer therapy. Int. J. Cell. Biol., 2010, 930509.
84. Szegezdi, E., Logue, S. E., Gorman, A. M. and Samali, A. (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep., 7, 880-885. (Pubitemid 44523966)
85. Ravasco, P., Aranha, M. M., Borralho, P. M., Moreira da Silva, I. B., Correia, L., Fernandes, A., Rodrigues, C. M. and Camilo, M. (2010) Colorectal cancer: can nutrients modulate NF-kappa B and apoptosis? Clin. Nutr., 29, 42-46.
86. Jover, R., Payá, A., Alenda, C., Poveda, M. J., Peiró, G., Aranda, F. I. and Pérez-Mateo, M. (2004) Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. Am. J. Clin. Pathol., 122, 389-394. (Pubitemid 39145544)